Browse by Medical Category
Accepting New Patients: Call for Availability
Dr. Kronenberg is an endocrinologist, internist, and scientist with a focus on bone and mineral metabolism and actions of parathyroid hormone.
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Henry M. Kronenberg is Chief of the Endocrine Unit at the Massachusetts General Hospital and Professor of Medicine at the Harvard Medical School. There he leads a research group that studies the actions of parathyroid hormone and parathyroid hormone-related protein, with a particular emphasis on bone development, bone biology, calcium homeostasis, and the roles of osteoblast-lineage cells in hematopoiesis. Dr. Kronenberg's laboratory in recent years has used a number of genetically altered strains of mice to establish the role of signaling by the PTH/PTHrP receptor in bone. Dr. Kronenberg has a small practice in Endocrine Associates.
Dr. Kronenberg received his BA from Harvard University, his MD from Columbia University, his medical house officer training at the Massachusetts General Hospital, and post-doctoral training at NIH, MIT, and the MGH.Dr. Kronenberg has served as President of the American Society for Bone and Mineral Research and as a member of the Board of Directors of the International Bone and Mineral Society (IBMS); he is currently the Vice President of the IBMS. He has served on the Council of the Endocrine Society and the Endocrine Society's Vice President for Basic Science; he has served as the Endocrine Society's representative on the FASEB Board of Directors. He has served on the General Medicine B NIH Study Section and as a member of the Board of Scientific Counselors of the National Institute of Dental and Craniofacial Research; he is currently on the Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
The MGH Endocrinology Unit hosted a special reception on Sept. 29 to commemorate a 28-year collaboration with the Chugai Pharmaceutical Co., Ltd, of Japan. Since 1989, 10 scientists from Chugai have come to spend two to three years each as visiting research scientists in the hospital's endocrinology laboratories.
Back to Top